|Status : Upcoming||Report Code : VRHC1118||Industry : Healthcare||Available Format :|
Industry Insights by Product (Urology Endoscopes (Cystoscopes, Laparoscopes, Nephroscopes, Ureteroscopes, and Resectoscopes), Peripheral Instruments (Insufflators, and Endoscopy Fluid Management Systems), Endovision Systems (Endoscopic Light Sources, Wireless Monitors and Displays, Endoscopic Cameras, and Camera Heads) and Consumables and Accessories (Guidewires, Dilator Set and Ureteral Access Sheath, Stone Basket/Retrieval Device and Extractor, Surgical Dissectors, Catheter, Connecting Tube, Stent, biopsy Device, Fluid Flushing Device, Needle Forceps and Needle Holders, Clamp, Drainage Bag, and Other Products)), and by Application (Chronic Kidney Disease, Urinary Stones, Oncology, Benign Prostatic Hyperplasia (BPH), Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP), and Other Applications)
Urology surgical instrument is used for the treatment of conditions such as chronic kidney diseases, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, oncology, urinary stone, and others. The global urology surgical instrument market is growing at a significant rate, due to the mounting occurrence of kidney diseases and urinary tract infections and expanding investments, funds, and grants by government bodies.
Different products such as urology endoscopes, peripheral instruments, endovision systems, and consumables and accessories contributed to the urology surgical instrument market size. The market has witnessed high demand for consumables and accessories in the due to mounting surgical intervention for urology conditions, expanding occurrence of chronic kidney disorders, and an upsurge in alertness of urology conditions at initial stages.
Insight by Product
On the basis of product, the market is subdivided into urology endoscopes, peripheral instruments, endovision systems, and consumables and accessories. Of all products, consumables and accessories segment accounted the largest share and is expected to grow at fastest rate in the market, due to mounting surgical intervention for urology conditions, expanding occurrence of chronic kidney disorders, elevated usage of guidewires, catheters, stone baskets, dilator set and stents in urological surgeries, improvements in minimally invasive surgeries, upsurge in alertness of urology conditions at initial stages, and expanding geriatric population.
The urology endoscopes segment is further subdivided into cystoscopes, laparoscopes, nephroscopes, ureteroscopes, and resectoscopes. The laparoscopes segment accounted the largest share in the market due to its enormous usage in minimally invasive surgeries. The peripheral instruments are further subdivided into insufflators and endoscopy fluid management systems. The insufflators segment accounted for larger share and is expected to grow at a faster rate in the market due to mounting acceptance of laparoscopic and hysteroscopic surgery.
The endovision systems are further subdivided into endoscopic light sources, wireless monitors and displays, endoscopic cameras, and camera heads. The endoscopic cameras segment accounted the largest share in the market due to its capability to provide imagining of the human body while carrying out the surgery.
The consumables and accessories are further subdivided into guidewires, dilator set and ureteral access sheath, stone basket/retrieval device and extractor, surgical dissectors, catheter, connecting tube, stent, a biopsy device, fluid flushing device, needle forceps and needle holders, clamp, drainage bag, and other products. The guidewires segment accounted the largest share in the market due to smooth tracking, accurate control, stress-free progression, and maximum maneuverability during surgical procedures.
Insight by Application
On the basis of application, the market is subdivided into chronic kidney disease, urinary stones, oncology, benign prostatic hyperplasia (BPH), urinary incontinence (UI) and pelvic organ prolapse (POP), and other applications. Among all applications, the chronic kidney disease application accounted the largest share in the urology surgical instrument market. In addition, urinary incontinence (UI) and pelvic organ prolapse (POP) application is expected to grow at fastest rate in the market, due to the mounting occurrence of urinary incontinence, and expanding alertness of the condition.
Mounting occurrence of kidney diseases and urinary tract infections, escalating occurrence of benign prostatic hyperplasia procedures, expanding the geriatric population, escalating hospital investments in surgical infrastructure are the primary growth drivers for urology surgical instrument market.
A mounting number of free-trade agreements, escalating healthcare expenditure and mounting inclination towards minimally invasive surgeries, expanding investments, funds, and grants by government bodies are also facilitating the growth for the urology surgical instrument market.
Elevated price of urology endoscopes and endovision systems, unfavorable healthcare reforms, side-effects associated with the surgical procedure, and elevated mortality rates urology procedures are the major challenges for the growth of urology surgical instrument market.
Globally, the manufacturing companies trying to enter the urology surgical instrument market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest urology surgical instrument market as in the region the occurrence of urology cancer is elevated and favorable reimbursement scenario. In addition, a mounting number of ambulatory surgical centers, and government initiatives to prevent prostate cancer are also up surging growth of the North American urology surgical instrument market.
Asia-Pacific is observed to witness the fastest growth in the market, due to improving healthcare infrastructure. In addition, mounting acceptance of minimally invasive surgery, and expanding medical tourism are also creating a positive impact on the urology surgical instrument market growth in the region.
Key players in the urology surgical instrument market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In October 2018, NeoTract, a subsidiary of Teleflex Incorporated present new clinical data on UroLift System for patients with benign prostatic hyperplasia at Annual Meeting of the American Urology Association in Toronto, Ontario. Olympus Corporation, Coloplast A/S, Medtronic PLC, Conmed Corporation, Karl Storz GmbH & Co. Kg, Teleflex Incorporated, Cook Medical Incorporated, Stryker Corporation, Richard Wolf GmbH, and Boston Scientific Corporation are the key players offering urology surgical instrument.